Valuation: Fisher & Paykel Healthcare Corporation Limited

Market Cap 23.64B 13.64B 11.93B 11.01B 10.16B 19.29B 1,301B 19.61B 131B 51.64B 641B 51.22B 50.1B 2,203B P/E 2027 *
43.9x
P/E 2028 * 37.1x
Enterprise Value 23.17B 13.37B 11.7B 10.79B 9.96B 18.91B 1,275B 19.22B 129B 50.62B 628B 50.21B 49.11B 2,160B EV / Sales 2027 *
9.13x
EV / Sales 2028 * 8.1x
Free-Float
96.31%
Yield 2027 *
1.48%
Yield 2028 * 1.7%

Last Transcript: Fisher & Paykel Healthcare Corporation Limited

1 day+1.13%
1 week+1.36%
Current month+3.18%
1 month+3.79%
3 months+4.44%
6 months+4.71%
Current year+6.62%
1 week 39.1
Extreme 39.1
41
1 month 37.29
Extreme 37.29
41
Current year 32.16
Extreme 32.16
41.4
1 year 32.16
Extreme 32.16
41.4
3 years 20.29
Extreme 20.29
41.4
5 years 18.02
Extreme 18.02
41.4
10 years 8.13
Extreme 8.13
41.4
Manager TitleAgeSince
Chief Executive Officer 65 01/04/2016
Director of Finance/CFO - 01/03/2019
Chief Operating Officer - 01/04/2024
Director TitleAgeSince
Director/Board Member 68 01/11/2001
Director/Board Member 65 01/04/2016
Chairman 67 28/08/2024
Date Insider Type Main position Quantity % Market Cap.
06-02Buy

Director

1,000 0.0002%
04-01Buy

Responsable ventes & marketing

129 0.0000%
01-16Buy

Responsable ventes & marketing

145 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.13%+1.36%+13.00%+66.25% 13.64B
-0.50%-1.54%-28.85%-12.62% 164B
+1.80%+0.82%-6.73%-3.92% 107B
+0.32%+2.34%+2.79%+57.04% 59.04B
+0.79%-3.68%+39.99%+54.50% 51.72B
+0.72%-3.88%-13.66%-41.41% 41.87B
+0.47%-4.98% - - 34.7B
+2.66%+5.21%-10.09%-42.88% 28.93B
-1.10%-3.29%+55.70%-5.76% 24.99B
0.00%-1.01%-5.28%-3.57% 21.05B
Average +0.63%-0.79%+5.21%+7.51% 54.69B
Weighted average by Cap. +0.52%-0.87%-5.11%+2.76%

Financials

2027 *2028 *
Net sales 2.54B 1.46B 1.28B 1.18B 1.09B 2.07B 140B 2.11B 14.12B 5.54B 68.82B 5.5B 5.38B 237B 2.84B 1.64B 1.43B 1.32B 1.22B 2.32B 156B 2.35B 15.78B 6.2B 76.93B 6.15B 6.01B 264B
Net income 542M 313M 274M 252M 233M 442M 29.83B 450M 3.02B 1.18B 14.7B 1.17B 1.15B 50.53B 640M 369M 323M 298M 275M 522M 35.19B 531M 3.56B 1.4B 17.34B 1.39B 1.36B 59.6B
Net Debt -466M -269M -235M -217M -200M -380M -25.64B -386M -2.59B -1.02B -12.63B -1.01B -987M -43.42B -646M -373M -326M -301M -278M -527M -35.58B -536M -3.6B -1.41B -17.53B -1.4B -1.37B -60.25B
Logo Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.
Employees
7,396
Date Price Change Volume
09/07/26 NZ$40.25 +1.13% 581,090
08/07/26 NZ$39.80 -2.64% 291,662
07/07/26 NZ$40.88 +1.31% 434,848
06/07/26 NZ$40.35 +1.61% 286,393
03/07/26 NZ$39.71 +1.72% 309,350
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
40.25NZD
Average target price
39.71NZD
Spread / Average Target
-1.33%

Quarterly revenue - Rate of surprise